NO924929L - Farmasoeytisk aktive benzoquinazolinforbindelser - Google Patents

Farmasoeytisk aktive benzoquinazolinforbindelser

Info

Publication number: NO924929L
Authority: NO; Norway
Prior art keywords: group; compounds; pharmasoeytic; active; optionally substituted
Prior art date: 1990-06-19

Application number

NO92924929A

Other languages

English (en)

Norwegian (no)

Other versions

NO924929D0 (no

Inventor

William Pendergast

Scott Howard Dickerson

Julius Vass Johnson

Robert Ferone

Original Assignee

Wellcome Found

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-06-19

Filing date

1992-12-18

Publication date

1992-12-18

1992-12-18 Application filed by Wellcome Found filed Critical Wellcome Found

1992-12-18 Publication of NO924929D0 publication Critical patent/NO924929D0/no

1992-12-18 Publication of NO924929L publication Critical patent/NO924929L/no

Links

PQIUGRLKNKSKTC-UHFFFAOYSA-N benzo[h]quinazoline Chemical class N1=CN=C2C3=CC=CC=C3C=CC2=C1 PQIUGRLKNKSKTC-UHFFFAOYSA-N 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 2
206010028980 Neoplasm Diseases 0.000 abstract 1
125000001931 aliphatic group Chemical group 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
125000001475 halogen functional group Chemical group 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000002831 pharmacologic agent Substances 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

NO92924929A 1990-06-19 1992-12-18 Farmasoeytisk aktive benzoquinazolinforbindelser NO924929L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GB909013615A GB9013615D0 (en)	1990-06-19	1990-06-19	Pharmaceutical compounds
PCT/GB1991/000977 WO1991019700A1 (en)	1990-06-19	1991-06-18	Pharmaceutically active benzoquinazoline compounds

Publications (2)

Publication Number	Publication Date
NO924929D0 NO924929D0 (no)	1992-12-18
NO924929L true NO924929L (no)	1992-12-18

Family

ID=10677828

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO92924929A NO924929L (no)	1990-06-19	1992-12-18	Farmasoeytisk aktive benzoquinazolinforbindelser

Country Status (26)

Country	Link
US (4)	US6090941A (de)
EP (2)	EP0535034B1 (de)
JP (1)	JP2966929B2 (de)
KR (1)	KR0183042B1 (de)
CN (1)	CN1049215C (de)
AP (1)	AP218A (de)
AT (2)	ATE260262T1 (de)
AU (1)	AU639815B2 (de)
CA (1)	CA2085589C (de)
CS (1)	CS186391A3 (de)
DE (2)	DE69133371T2 (de)
DK (2)	DK1199307T3 (de)
ES (2)	ES2178632T3 (de)
FI (1)	FI925778A0 (de)
GB (1)	GB9013615D0 (de)
HU (2)	HUT62273A (de)
IE (1)	IE912073A1 (de)
IL (1)	IL98542A (de)
MC (1)	MC2290A1 (de)
MY (1)	MY107001A (de)
NO (1)	NO924929L (de)
NZ (1)	NZ238582A (de)
PL (1)	PL169927B1 (de)
PT (1)	PT98021B (de)
WO (1)	WO1991019700A1 (de)
ZA (1)	ZA914676B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9013615D0 (en)	1990-06-19	1990-08-08	Wellcome Found	Pharmaceutical compounds
US6762188B1 (en)	1990-06-19	2004-07-13	Smithkline Beecham Corporation	Pharmaceutically active benzoquinazoline compounds
GB9223352D0 (en) *	1992-11-06	1992-12-23	Ici Plc	Tricyclic compounds
GB9226842D0 (en) *	1992-12-23	1993-02-17	Wellcome Found	Pharmaceutical compounds
GB9408936D0 (en) *	1994-05-05	1994-06-22	Cancer Res Inst	Anti-cancer compounds
AU3883600A (en)	1999-03-16	2000-10-04	Regents Of The University Of California, The	Glycosylated polyamines
US6531454B1 (en)	1999-03-16	2003-03-11	The Regents Of The University Of California	Glycosylated polyamines and methods of use therefor
US6689381B2 (en)	2000-06-09	2004-02-10	Osi Pharmaceuticals, Inc.	Liposomal benzoquinazoline thymidylate synthase inhibitor formulations
RU2004112787A (ru) *	2001-09-26	2005-10-10	Байер Фармасьютикалс Корпорейшн (US)	Производные 1,6-нафтиридина как противодиабетические средства
CN100434425C (zh) *	2005-03-09	2008-11-19	首都师范大学	4-喹唑啉酮衍生物及其在抗肿瘤药物中的应用
EP1754484A1 (de)	2005-08-17	2007-02-21	Dan Stoicescu	Kondensierte Pyrimidinderivative als Inhibitoren der Folsäure-abhängiger Enzyme
EP2077290B1 (de)	2005-12-05	2010-04-21	Nitto Denko Corporation	Polyglutamat-Aminosäure-Konjugate und Verfahren
GB0525069D0 (en) *	2005-12-08	2006-01-18	Novartis Ag	Organic compounds
CA2663436A1 (en)	2006-10-04	2008-04-10	Pfizer Products Inc.	Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists
EP1958632A1 (de)	2007-02-14	2008-08-20	Dan Stoicescu	Kondensierte Pyrimidinderivaten zur Behandlung von Entzündungserkrankungen und Autoimmunerkrankungen
ES2430380T3 (es) *	2007-05-09	2013-11-20	Nitto Denko Corporation	Composiciones que incluyen un compuesto hidrófobo y un conjugado de poliaminoácido
CN101730549B (zh) *	2007-05-09	2015-12-09	日东电工株式会社	与铂类药物结合的聚合物
EP2155253A2 (de) *	2007-05-09	2010-02-24	Nitto Denko Corporation	Polyglutamatkonjugate und polyglutamat-aminosäure-konjugate mit mehreren wirkstoffen
US8146622B2 (en)	2007-08-20	2012-04-03	Ford Global Technologies, Llc	Switch and hose-valve connection arrangement for vehicle temporary mobility kit
US8517760B2 (en)	2007-08-20	2013-08-27	Ford Global Technologies, Llc	Cord wrap and power plug receptacle arrangement for inflator
WO2010138955A2 (en)	2009-05-29	2010-12-02	University Of Florida Research Foundation, Inc.	Methods and compositions for treating neoplasia
CN101580501B (zh)	2009-06-01	2011-03-09	南京卡文迪许生物工程技术有限公司	3-(取代二氢异吲哚酮-2-基)-2,6-哌啶二酮的合成方法及其中间体
WO2011078226A1 (ja) *	2009-12-22	2011-06-30	協和発酵キリン株式会社	三環系化合物
CN116547280A (zh) *	2020-10-08	2023-08-04	雷多纳治疗公司	用于治疗癌症的苯并[h]喹唑啉-4-胺和噻吩并[3,2-h]喹唑啉-4-胺衍生物
IL301964A (en)	2020-10-08	2023-06-01	Redona Therapeutics Inc	History of benzo[H]quinazoline-4-amine and thiano[2,3-H]quinazoline-4-amine for cancer treatment

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
UST862021I4 (en) *	1969-01-27	1969-05-27		Defensive publication
DE2202847A1 (de) *	1971-02-05	1972-08-17	Apaw Sa	Speiseeismaschine,insbesondere fuer Familiengebrauch,Kleinbetriebe od.dgl.
EP0031237B1 (de) *	1979-12-19	1984-10-17	National Research Development Corporation	Chinazolinderivate, Verfahren zu ihrer Herstellung, sie enthaltende Zusammensetzungen und ihre Verwendung als Anti-Krebs-Mittel
US4814335A (en) *	1982-12-30	1989-03-21	Biomeasure, Incorporated	Antiviral compounds
GB8513754D0 (en) *	1985-05-31	1985-07-03	Jones T R	Anti-cancer quinazoline derivatives
US4603186A (en)	1985-10-21	1986-07-29	The Standard Oil Company	Tetrapolymers containing indene
GB8607683D0 (en) *	1986-03-27	1986-04-30	Ici Plc	Anti-tumor agents
US4818819A (en) *	1986-10-20	1989-04-04	The Trustees Of Princeton University	Process for the preparation of fused pyridine compounds
GB8707053D0 (en) *	1987-03-25	1987-04-29	Ici Plc	Anti-tumour agents
US4857530A (en) *	1987-11-03	1989-08-15	Warner-Lambert Company	Substituted quinazolinones as anticancer agents
US4902624A (en) *	1987-11-23	1990-02-20	Eastman Kodak Company	Temperature cycling cuvette
GB8727737D0 (en) *	1987-11-26	1987-12-31	Ici Plc	Antitumour agents
GB8829296D0 (en) *	1988-12-15	1989-01-25	Ici Plc	Anti-tumour compounds
GB9013615D0 (en) *	1990-06-19	1990-08-08	Wellcome Found	Pharmaceutical compounds
US5405851A (en) *	1990-06-19	1995-04-11	Burroughs Wellcome Co.	Pharmaceutical compounds

1990
- 1990-06-19 GB GB909013615A patent/GB9013615D0/en active Pending
1991
- 1991-06-18 CS CS911863A patent/CS186391A3/cs unknown
- 1991-06-18 CN CN91105021A patent/CN1049215C/zh not_active Expired - Fee Related
- 1991-06-18 CA CA002085589A patent/CA2085589C/en not_active Expired - Lifetime
- 1991-06-18 ES ES91910823T patent/ES2178632T3/es not_active Expired - Lifetime
- 1991-06-18 EP EP91910823A patent/EP0535034B1/de not_active Expired - Lifetime
- 1991-06-18 AP APAP/P/1991/000283A patent/AP218A/en active
- 1991-06-18 AT AT02075192T patent/ATE260262T1/de not_active IP Right Cessation
- 1991-06-18 DK DK02075192T patent/DK1199307T3/da active
- 1991-06-18 JP JP3510950A patent/JP2966929B2/ja not_active Expired - Fee Related
- 1991-06-18 HU HU924011A patent/HUT62273A/hu unknown
- 1991-06-18 PT PT98021A patent/PT98021B/pt not_active IP Right Cessation
- 1991-06-18 MY MYPI91001094A patent/MY107001A/en unknown
- 1991-06-18 DE DE69133371T patent/DE69133371T2/de not_active Expired - Fee Related
- 1991-06-18 WO PCT/GB1991/000977 patent/WO1991019700A1/en not_active Ceased
- 1991-06-18 DK DK91910823T patent/DK0535034T3/da active
- 1991-06-18 NZ NZ238582A patent/NZ238582A/en unknown
- 1991-06-18 ES ES02075192T patent/ES2211851T3/es not_active Expired - Lifetime
- 1991-06-18 IE IE207391A patent/IE912073A1/en unknown
- 1991-06-18 KR KR1019920703287A patent/KR0183042B1/ko not_active Expired - Fee Related
- 1991-06-18 MC MC91@@D patent/MC2290A1/xx unknown
- 1991-06-18 IL IL9854291A patent/IL98542A/en not_active IP Right Cessation
- 1991-06-18 DE DE69133088T patent/DE69133088T2/de not_active Expired - Fee Related
- 1991-06-18 AT AT91910823T patent/ATE222243T1/de not_active IP Right Cessation
- 1991-06-18 EP EP02075192A patent/EP1199307B1/de not_active Expired - Lifetime
- 1991-06-18 ZA ZA914676A patent/ZA914676B/xx unknown
- 1991-06-18 AU AU80943/91A patent/AU639815B2/en not_active Ceased
- 1991-06-18 PL PL91297195A patent/PL169927B1/pl unknown
1992
- 1992-12-18 FI FI925778A patent/FI925778A0/fi not_active Application Discontinuation
- 1992-12-18 NO NO92924929A patent/NO924929L/no unknown
1993
- 1993-01-13 US US07/956,018 patent/US6090941A/en not_active Expired - Fee Related
1995
- 1995-05-12 HU HU95P/P00133P patent/HU211265A9/hu unknown
- 1995-05-25 US US08/449,959 patent/US5663337A/en not_active Expired - Lifetime
- 1995-05-26 US US08/452,337 patent/US5661155A/en not_active Expired - Lifetime
2000
- 2000-06-06 US US09/588,790 patent/US6306865B1/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
ES2211851T3 (es)	2004-07-16
PT98021B (pt)	1998-11-30
AU8094391A (en)	1992-01-07
DE69133088D1 (de)	2002-09-19
AU639815B2 (en)	1993-08-05
EP0535034B1 (de)	2002-08-14
DK1199307T3 (da)	2004-06-14
US5661155A (en)	1997-08-26
WO1991019700A1 (en)	1991-12-26
CA2085589A1 (en)	1991-12-20
CA2085589C (en)	2001-12-18
NO924929D0 (no)	1992-12-18
IL98542A0 (en)	1992-07-15
MC2290A1 (fr)	1993-07-14
PT98021A (pt)	1992-04-30
US6090941A (en)	2000-07-18
AP218A (en)	1992-09-27
MY107001A (en)	1995-08-30
IL98542A (en)	1995-05-26
US6306865B1 (en)	2001-10-23
EP1199307B1 (de)	2004-02-25
FI925778A7 (fi)	1992-12-18
ATE222243T1 (de)	2002-08-15
KR930701415A (ko)	1993-06-11
AP9100283A0 (en)	1991-07-31
ATE260262T1 (de)	2004-03-15
JPH05507704A (ja)	1993-11-04
CN1058208A (zh)	1992-01-29
PL169927B1 (pl)	1996-09-30
DE69133371D1 (de)	2004-04-01
HU211265A9 (en)	1995-11-28
NZ238582A (en)	1993-12-23
FI925778A0 (fi)	1992-12-18
EP1199307A1 (de)	2002-04-24
CS186391A3 (en)	1992-04-15
HUT62273A (en)	1993-04-28
DK0535034T3 (da)	2002-12-09
HU9204011D0 (en)	1993-03-29
ES2178632T3 (es)	2003-01-01
GB9013615D0 (en)	1990-08-08
EP0535034A1 (de)	1993-04-07
KR0183042B1 (ko)	1999-05-01
DE69133088T2 (de)	2003-03-20
CN1049215C (zh)	2000-02-09
ZA914676B (en)	1993-02-24
DE69133371T2 (de)	2005-01-27
IE912073A1 (en)	1992-01-01
US5663337A (en)	1997-09-02
JP2966929B2 (ja)	1999-10-25

Publication	Publication Date	Title
HUT74367A (en)	1996-12-30	Fungicidal alpha-aryl-substituted cyclic amide derivatives, fungicid compositions containing these as active ingredients and using thereof
HUP9802814A2 (hu)	1999-10-28	Szelektív béta3 adrenergiás agonista hatású vegyületek, e vegyületeket tartalmazó gyógyászati készítmények, eljárás előállításukra és alkalmazásuk
HUP9903766A2 (en)	2000-09-28	Pyridyl alkene- and pyridyl alkine- acid amides, use of them as cytostatics and immunosuppressives, process for their preparation and pharmaceuticals containing the same
ES482134A1 (es)	1980-04-01	Un procedimiento para preparar derivados de 1-(3-mercapto- 2-metilpropanoil)-prolil-aminoacido.
CA2256582A1 (en)	1997-12-11	Oxa acids and related compounds for treating skin conditions
EP0324387A3 (en)	1990-06-13	Composition for treatment of ischemic disorder in organs
NO996108L (no)	2000-02-10	9-oksinerytromycinderivater
HUP9902017A2 (hu)	1999-09-28	Aminosav- és hidroxisav-származékokkal szubsztituált benzamidinszármazékok és antikoagulánsokként történő alkalmazásuk
GR3018086T3 (en)	1996-02-29	Heterocyclic bisphosphonic acid derivatives.
DK151627C (da)	1988-06-20	Analogifremgangsmaade til fremstilling af terapeutisk virksomme 4-(fenylalkenyl)-imidazolderivater eller ugiftige, farmaceutisk acceptable syreadditionssalte deraf.
NO812355L (no)	1982-01-13	Analogifremgangsmaate for fremstilling av terapeutisk aktive 3,1-benzoksazin-2-on-derivater
DK597687D0 (da)	1987-11-13	Imidazolidinonforbindelse, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat dermed
DE3362504D1 (en)	1986-04-17	1-carboxyalkanoylindoline-2-carboxylic-acid esters, their preparation, pharmaceutical compositions containing them, and their therapeutic use
HUT53664A (en)	1990-11-28	Process for producing enzyme inhibiting amino acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient
DK179788A (da)	1988-10-02	N-aryl-piperazinalkanamidderivater, fremgangsmaade til fremstilling deraf, praeparater indeholdende samme samt anvendelse af saadanne derivater til fremstilling af farmaceutisk aktive praeparater
DK469687A (da)	1988-03-11	Derivater af 4,5-dihydrooxazoler og fremgangsmaade til fremstilling af saadanne derivater.
ZA912618B (en)	1992-01-29	3-aminochroman derivatives,process for preparing these and pharmaceutical compositions containing them
IE893956L (en)	1990-06-19	Novel compounds
NO923004L (no)	1993-02-01	6-oxo-azepinoindolforbindelser, saavel som fremgangsmaater og mellomprodukter for fremstilling av disse, og legemidler inneholdende disse forbindelser
AU4304596A (en)	1996-07-10	A process for the preparation of substituted 4-ethyl-piperidines and an intermediate for the preparation of same
NO20003138L (no)	2000-08-18	Ny anvendelse av lokalanestetika mot vaskulære hodepiner
MY106786A (en)	1995-07-31	Novel antiviral tetrahydroimidazo [1,4] benzodiazepin -2- (thi)ones
TR200000154T2 (tr)	2000-06-21	2,4,4-Trisübstitüe-1,3-Dioksolan mantar önleyiciler.
DK0619817T3 (da)	1999-09-27	Hidtil ukendte farmaceutisk aktive flaviliumforbindelser
IL106862A0 (en)	1993-12-28	Novel oxazolidines and pharmaceutical compositions containing them